Cooper; Eugene R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cooper; Eugene R..The latest application filed is for "formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases".

Company Profile

8.46.50

Cooper; Eugene R. - Berwyn PA
Cooper; Eugene R - Berwyn PA US
Cooper; Eugene R. - King of Prussia PA
Cooper; Eugene R. - Crowley TX
Cooper; Eugene R. - Cincinnati OH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Formulations Of Cannabinoids For The Treatment Of Dermatitis And Inflammatory Skin Diseases App 20210401768 - Cooper; Eugene R. ; et al.	2021-12-30
Nanoparticulate Meloxicam Formulations App 20210113580 - COOPER; Eugene R. ; et al.	2021-04-22
Nanoparticulate meloxicam formulations Grant 10,709,713 - Cooper , et al.	2020-07-14
Nanoparticulate Meloxicam Formulations App 20200155564 - Cooper; Eugene R. ; et al.	2020-05-21
Compositions For Treating Acne App 20200022927 - Cooper; Eugene R. ; et al.	2020-01-23
Compositions and Methods for Treatment of Infections App 20200009253 - Cooper; Eugene R. ; et al.	2020-01-09
Nanoparticulate Meloxicam Formulations App 20190381062 - Cooper; Eugene R. ; et al.	2019-12-19
Nanoparticulate meloxicam formulations Grant 10,471,067 - Cooper , et al. Nov	2019-11-12
Nanoparticulate meloxicam formulations Grant 10,463,673 - Cooper , et al. No	2019-11-05
Nanoparticulate Meloxicam Formulations App 20180228809 - Cooper; Eugene R. ; et al.	2018-08-16
Nanoparticulate Meloxicam Formulations App 20180228810 - Cooper; Eugene R. ; et al.	2018-08-16
Compositions for depositing agents using highly volatile silicone solvents Grant 9,844,596 - Cooper , et al. December 19, 2	2017-12-19
Nanoparticulate Meloxicam Formulations App 20170157061 - Cooper; Eugene R. ; et al.	2017-06-08
Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic Grant 9,283,177 - Cohen , et al. March 15, 2	2016-03-15
Small molecule solubilization system Grant 9,050,293 - Cohen , et al. June 9, 2	2015-06-09
Bi-functional co-polymer use for opthalmic and other topical and local applications Grant 8,802,075 - Cooper , et al. August 12, 2	2014-08-12
Compositions for Depositing Agents Using Highly Volatile Silicone Solvents App 20140199249 - Cooper; Eugene R. ; et al.	2014-07-17
Topical anesthetic for rapid local anesthesia Grant 8,759,391 - Cohen , et al. June 24, 2	2014-06-24
Nanoparticulate Meloxicam Formulations App 20140141083 - Cooper; Eugene R. ; et al.	2014-05-22
Abuse-resistant Pharmaceutical Compositions App 20140112980 - Vaghefi; Farid ; et al.	2014-04-24
Compositions And Methods For Treatment Of Infections App 20140079804 - Cooper; Eugene R. ; et al.	2014-03-20
Compositions and Methods for Treatment of Infections App 20140044658 - Cooper; Eugene R. ; et al.	2014-02-13
Abuse-resistant pharmaceutical compositions Grant 8,623,412 - Farid , et al. January 7, 2	2014-01-07
Nanoparticulate meloxicam formulations Grant 8,512,727 - Cooper , et al. August 20, 2	2013-08-20
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions Grant 8,309,136 - Cooper , et al. November 13, 2	2012-11-13
Dry Powder Aerosols Of Nanoparticulate Drugs App 20120213829 - Bosch; H. William ; et al.	2012-08-23
Propellant-based nanoparticulate dry powder aerosols and method of making Grant 8,124,057 - Bosch , et al. February 28, 2	2012-02-28
Transscleral Delivery App 20120034279 - COOPER; Eugene R. ; et al.	2012-02-09
Ophthalmic Formulations Of Reversed Liquid Crystalline Phase Materials And Methods Of Using App 20110177169 - Anderson; David ; et al.	2011-07-21
Nanoparticulate statin formulations and novel statin combinations App 20110027371 - Cooper; Eugene R. ; et al.	2011-02-03
Bioadhesive nanoparticulate compositions having cationic surface stabilizers Grant 7,850,995 - Bosch , et al. December 14, 2	2010-12-14
Nanoparticulate Meloxicam Formulations App 20100297252 - Cooper; Eugene R. ; et al.	2010-11-25
Bi-functional Co-polymer Use For Opthalmic And Other Topical And Local Applications App 20100226963 - Cooper; Eugene R. ; et al.	2010-09-09
Nanoparticulate polycosanol formulations and novel polycosanol combinations Grant 7,763,278 - Cooper , et al. July 27, 2	2010-07-27
In Vitro Methods For Evaluating The In Vivo Effectiveness Of Dosage Forms Of Microparticulate Or Nanoparticulate Active Agent Compositions App 20100178648 - Cooper; Eugene R. ; et al.	2010-07-15
Nanoparticulate Polycosanol Formulations & Novel Polycosanol Combinations App 20100143962 - COOPER; Eugene R. ; et al.	2010-06-10
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions Grant 7,695,739 - Cooper , et al. April 13, 2	2010-04-13
Small Molecule Solubilization System App 20100016442 - Cohen; David M. ; et al.	2010-01-21
Transscleral Delivery App 20090324689 - COOPER; Eugene R. ; et al.	2009-12-31
Transscleral Delivery App 20090324686 - Cooper; Eugene R. ; et al.	2009-12-31
Transscleral Delivery App 20090324688 - COOPER; Eugene R. ; et al.	2009-12-31
Transscleral Delivery App 20090324687 - Cooper; Eugene R. ; et al.	2009-12-31
Transscleral Delivery App 20090324690 - Cooper; Eugene R. ; et al.	2009-12-31
Transscleral delivery Grant 7,585,517 - Cooper , et al. September 8, 2	2009-09-08
Local anti-infective agent for treatment of nail fungal infections App 20090192125 - Cohen; David M. ; et al.	2009-07-30
Dry powder aerosols of Nanoparticulate drugs App 20090181100 - Bosch; H. William ; et al.	2009-07-16
Dry powder aerosols of nanoparticulate drugs Grant 7,521,068 - Bosch , et al. April 21, 2	2009-04-21
Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic App 20090048347 - Cohen; David M. ; et al.	2009-02-19
Nanoparticulate statin formulations and novel statin combinations App 20080213378 - Cooper; Eugene R. ; et al.	2008-09-04
Local anti-infective agent for treatment of nail fungal infections App 20080193508 - Cohen; David M. ; et al.	2008-08-14
Topical Anesthetic for Rapid Local Anesthesia and Method of Applying a Topical Anesthetic App 20080176948 - Cohen; David M. ; et al.	2008-07-24
Nanoparticulate topiramate formulations Grant 7,390,505 - Gustow , et al. June 24, 2	2008-06-24
Bioadhesive nanoparticulate compositions having cationic surface stabilizers App 20080003295 - Bosch; H. William ; et al.	2008-01-03
Bioadhesive nanoparticulate compositions having cationic surface stabilizers Grant 7,288,267 - Bosch , et al. October 30, 2	2007-10-30
In vitro methods for evaluating the in vivo effectivness of dosage forms of microparticulate or nanoparticulate active agent compositions App 20070110776 - Cooper; Eugene R. ; et al.	2007-05-17
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions Grant 7,198,795 - Cooper , et al. April 3, 2	2007-04-03
Abuse-resistant pharmaceutical compositions App 20060104909 - Vaghefi; Farid ; et al.	2006-05-18
Compositions having a combination of immediate release and controlled release characteristics Grant 6,908,626 - Cooper , et al. June 21, 2	2005-06-21
Transscleral delivery App 20050064010 - Cooper, Eugene R. ; et al.	2005-03-24
Nanoparticulate topiramate formulations App 20040258758 - Gustow, Evan ; et al.	2004-12-23
Nanoparticulate meloxicam formulations App 20040229038 - Cooper, Eugene R. ; et al.	2004-11-18
Liquid droplet aerosols of nanoparticulate drugs Grant 6,811,767 - Bosch , et al. November 2, 2	2004-11-02
Milling microgram quantities of nanoparticulate candidate compounds App 20040173696 - Cunningham, James ; et al.	2004-09-09
Novel triamcinolone compositions App 20040141925 - Bosch, H. William ; et al.	2004-07-22
Novel benzoyl peroxide compositions App 20040101566 - Cooper, Eugene R. ; et al.	2004-05-27
Nanoparticulate sterol formulations and novel sterol combinations App 20040033202 - Cooper, Eugene R. ; et al.	2004-02-19
Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate App 20040029099 - Cooper, Eugene R. ; et al.	2004-02-12
Nanoparticulate polycosanol formulations & novel polycosanol combinations App 20030232796 - Cooper, Eugene R. ; et al.	2003-12-18
Compositions having a combination of immediate release and controlled release characteristics App 20030137067 - Cooper, Eugene R. ; et al.	2003-07-24
Bioadhesive nanoparticulate compositions having cationic surface stabilizers App 20030108611 - Bosch, H. William ; et al.	2003-06-12
Bioadhesive nanoparticulate compositions having cationic surface stabilizers Grant 6,428,814 - Bosch , et al. August 6, 2	2002-08-06
Aerosols Comprising Nanoparticle Drugs App 20020102294 - BOSCH, H. WILLIAM ; et al.	2002-08-01
Bioadhesive Nanoparticulate Compositions Having Cationic Surface Stabilizers App 20020068092 - BOSCH, H. WILLIAM ; et al.	2002-06-06
Biologically compatible linear block copolymers of polyalkylene oxide and peptide units Grant 5,853,713 - Cooper , et al. December 29, 1	1998-12-29
Pharmaceutical compositions containing polyalkylene block copolymers which gel at physiological temperature Grant 5,705,194 - Wong , et al. January 6, 1	1998-01-06
Biologically compatible linear block copolymers of polyalkylene oxide and peptide units Grant 5,618,528 - Cooper , et al. April 8, 1	1997-04-08
Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays Grant 5,585,108 - Ruddy , et al. December 17, 1	1996-12-17
Polyalkylene block copolymers as surface modifiers for nanoparticles Grant 5,565,188 - Wong , et al. October 15, 1	1996-10-15
X-ray contrast compositions useful in medical imaging Grant 5,451,393 - Liversidge , et al. September 19, 1	1995-09-19
X-ray contrast compositions containing an organic crystalline X-ray contrast agent in combination with pharmaceutically acceptable clays Grant 5,360,604 - Ruddy , et al. November 1, 1	1994-11-01
Compositions of iodophenoxy alkanes and iodophenyl ethers in film-forming materials for visualization of the gastrointestinal tract Grant 5,326,553 - Illig , et al. * July 5, 1	1994-07-05
Polymeric x-ray contrast compositions containing an organic crystalline x-ray contrast agent Grant 5,318,768 - Illig , et al. June 7, 1	1994-06-07
X-ray contrast compositions useful in medical imaging Grant 5,318,767 - Liversidge , et al. June 7, 1	1994-06-07
Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract Grant 5,316,755 - Illig , et al. * May 31, 1	1994-05-31
Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs Grant 5,221,696 - Ke , et al. June 22, 1	1993-06-22
Penetrating topical pharmaceutical compositions Grant 4,954,487 - Cooper , et al. September 4, 1	1990-09-04
Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one Grant 4,557,934 - Cooper December 10, 1	1985-12-10
Penetrating topical pharmaceutical compositions containing corticosteroids Grant 4,552,872 - Cooper , et al. November 12, 1	1985-11-12
Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone Grant 4,537,776 - Cooper August 27, 1	1985-08-27
Catheterization Grant 4,392,848 - Lucas , et al. July 12, 1	1983-07-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.